IDEAS home Printed from


by members of

Regional and International Economic Development Group
Management School
University of Liverpool
Liverpool, United Kingdom

These are publications listed in RePEc written by members of the above institution who are registered with the RePEc Author Service. Thus this compiles the works all those currently affiliated with this institution, not those affilated at the time of publication. List of registered members. Register yourself. Citation analysis. This page is updated in the first days of each month.
| Working papers | Journal articles |

Working papers


  1. Ken Wright & Alan Haycox, 1985. "Costs of alternative forms of NHS care for mentally handicapped persons," Working Papers 007chedp, Centre for Health Economics, University of York.


  1. Ken Wright & Alan Haycox, 1984. "Public sector costs of caring for mentally handicapped persons in a large hospital," Working Papers 001chedp, Centre for Health Economics, University of York.

Journal articles


  1. Cochrane, M. & Watson, P.M. & Timpson, H. & Haycox, A. & Collins, B. & Jones, L. & Martin, A. & Graves, L.E.F., 2019. "Systematic review of the methods used in economic evaluations of targeted physical activity and sedentary behaviour interventions," Social Science & Medicine, Elsevier, vol. 232(C), pages 156-167.


  1. Alan Haycox, 2018. "Should Low- and Middle-Income Countries Adopt Clinical Guidelines Developed in ‘Rich’ Countries?," PharmacoEconomics, Springer, vol. 36(7), pages 731-732, July.
  2. Arianit Jakupi & Brian Godman & Antony Martin & Alan Haycox & Indrit Baholli, 2018. "Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications," PharmacoEconomics - Open, Springer, vol. 2(4), pages 423-432, December.


  1. Alessandra Ferrario & Diāna Arāja & Tomasz Bochenek & Tarik Čatić & Dávid Dankó & Maria Dimitrova & Jurij Fürst & Ieva Greičiūtė-Kuprijanov & Iris Hoxha & Arianit Jakupi & Erki Laidmäe & Olga Löblová , 2017. "The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications," PharmacoEconomics, Springer, vol. 35(12), pages 1271-1285, December.


  1. Alan Haycox, 2016. "Why Cancer?," PharmacoEconomics, Springer, vol. 34(7), pages 625-627, July.


  1. Alan Haycox & Munir Pirmohamed & Claire McLeod & Rachel Houten & Sarah Richards, 2014. "Through a Glass Darkly: Economics and Personalised Medicine," PharmacoEconomics, Springer, vol. 32(11), pages 1055-1061, November.


  1. Alan Haycox, 2013. "How Much Should the NHS Pay for a QALY?," PharmacoEconomics, Springer, vol. 31(5), pages 357-359, May.


  1. Magda Wladysiuk & Aleksander Araszkiewicz & Brian Godman & Katarzyna Szabert & Corrado Barbui & Alan Haycox, 2011. "Influence of patient co-payments on atypical antipsychotic choice in Poland," Applied Health Economics and Health Policy, Springer, vol. 9(2), pages 101-110, March.


  1. Alan Haycox, 2007. "When NICE Says No!," PharmacoEconomics, Springer, vol. 25(12), pages 995-996, December.


  1. Alan Haycox, 2006. "Book Review: Valuing Health in Practice: Priorities, QALYs and Choice," Journal of Interdisciplinary Economics, , vol. 17(3), pages 345-347, April.


  1. Dyfrig A. Hughes & Adrian Bagust & Alan Haycox & Tom Walley, 2001. "The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 601-615, October.


  1. Johnes, Geraint & Haycox, Alan, 1986. "Cost structures in a large hospital for the mentally handicapped," Social Science & Medicine, Elsevier, vol. 22(6), pages 605-610, January.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.